Sign in to view content

Amine Oxidase Copper-Containing 3 Inhibitor (BI 1467335) in Non-Proliferative Diabetic Retinopathy: Double-Masked, Randomized, Phase IIa Study (ROBIN)

Quan Dong Nguyen, MD, MSc, FARVO, FASRS

Video
Published 2021

Related

What Happens to Diabetic Retinopathy Severity Scores With Less Aggressive Treatment? A Post Hoc Analysis of the RISE and RIDE Open Label Extension Study
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2019
Diabetic Retinopathy Telemedicine Outcomes With Artificial Intelligence-Based Image Analysis, Reflex Dilation, and Image Overread Protocol
Andrew J. Barkmeier, MD
Annual Meeting Talks
2021
Association Between Age-Related Macular Degeneration and Diabetic Retinopathy in Type 2 Diabetes Mellitus: A Retrospective Study Using the Vestrum Health Database
Daniel A. Adelberg, MD, FASRS
Annual Meeting Talks
2024

Category: Diabetic Retinopathy

See more